miR-21 downregulates the tumor suppressor P12CDK2AP1and stimulates cell proliferation and invasion

Journal of Cellular Biochemistry

Volumn 112, Issue 3, 2011, Pages 872-880

  Zheng, Jun ^a   Xue, Hui ^a   Wang, Tao ^a   Jiang, Yuegui ^b   Liu, Bei ^a   Li, Jianhu ^a   Liu, Yanpu ^a   Wang, Wei ^a   Zhang, Bin ^a   Sun, Moyi ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

CDK2AP1; HNSCCS; INVASION; MiR 21; PROLIFERATION

Indexed keywords

LUCIFERASE; MICRORNA 21; PROTEIN P12 CDK2AP1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CELL INVASION; CELL PROLIFERATION; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIMARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

3' UNTRANSLATED REGIONS; AGED; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEINS;

EID: 79951803234     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22995     Document Type: Article

References (41)

1. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136. (Pubitemid 351485639)
2. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
3. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. 2005. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120:21-24. (Pubitemid 40094599)
4. Cahill S, Smyth P, Finn SP, Denning K, Flavin R, O'Regan EM, Li J, Potratz A, Guenther SM, Henfrey R, O'Leary JJ, Sheils O. 2006. Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol Cancer 5:70.
5. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033. (Pubitemid 40994386)
6. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, Shan S, Westra W, Sidransky D, Califano JA. 2008. MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123(12):2791-2797.
7. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. 2005. Realtime quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179.
8. Daigo Y, Suzuki K, Maruyama O, Miyoshi Y, Yasuda T, Kabuto T, Imaoka S, Fujiwara T, Takahashi E, Fujino MA, Nakamura Y. 1997. Isolation, mapping and mutation analysis of a human cDNA homologous to the doc-1 gene of the Chinese hamster, a candidate tumor suppressor for oral cancer. Genes Chromosomes Cancer 20:204-207. (Pubitemid 27431146)
9. Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M. 2008. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 12:2171-2176.
10. Doench JG, Sharp PA. 2004. Specificity of microRNA target selection in translational repression. Genes Dev 18:504-511. (Pubitemid 38372808)
11. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. 2003. MicroRNA targets in Drosophila. Genome Biol 5:R1.
12. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
13. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. 2006. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140-D144.
14. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2008. miRBase: Tools for microRNA genomics. Nucleic Acids Res 36:D154-D158. (Pubitemid 351149713)
15. Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M, Baba H. 2009. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 15:1915-1922.
16. Hu MG, Hu GF, Kim Y, Tsuji T, McBride J, Hinds P, Wong DT. 2004. Role of p12(CDK2-AP1) in transforming growth factor-beta1-mediated growth suppression. Cancer Res 64:490-499. (Pubitemid 38120887)
17. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070. (Pubitemid 41161233)
18. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, Croce CM. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699-8707. (Pubitemid 47437445)
19. Kim Y, McBride J, Kimlin L, Pae EK, Deshpande A, Wong DT. 2009. Targeted inactivation of p12, CDK2 associating protein 1, leads to early embryonic lethality. PLoS ONE 4:e4518.
20. Kohno Y, Patel V, Kim Y, Tsuji T, Chin BR, Sun M, Bruce Donoff R, Kent R, Wong D, Todd R. 2002. Apoptosis, proliferation and p12(doc-1) profiles in normal, dysplastic and malignant squamous epithelium of the Syrian hamster cheek pouch model. Oral Oncol 38:274-280. (Pubitemid 34442549)
21. Kruger J, Rehmsmeier M. 2006. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34:W451-W454. (Pubitemid 44529811)
22. Le Guezennec X, Vermeulen M, Brinkman AB, Hoeijmakers WA, Cohen A, Lasonder E, Stunnenberg HG. 2006. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol 26:843-851. (Pubitemid 43146480)
23. Matsuo K, Shintani S, Tsuji T, Nagata E, Lerman M, McBride J, Nakahara Y, Ohyama H, Todd R, Wong DT. 2000. p12(DOC-1), a growth suppressor, associates with DNA polymerase alpha/primase. FASEB J 14:1318-1324. (Pubitemid 30439740)
24. Mazumder B, Seshadri V, Fox PL. 2003. Translational control by the 3′-UTR: The ends specify the means. Trends Biochem Sci 28:91-98. (Pubitemid 36165138)
25. Meister G, Landthaler M, Dorsett Y, Tuschl T. 2004. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10:544-550. (Pubitemid 38241013)
26. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T. 2006. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-2129. (Pubitemid 43816961)
27. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658. (Pubitemid 47187346)
28. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
29. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA 10:1507-1517. (Pubitemid 39288185)
30. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM. 2006. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:4677-4684. (Pubitemid 46630931)
31. Shintani S, Ohyama H, Zhang X, McBride J, Matsuo K, Tsuji T, Hu MG, Hu G, Kohno Y, Lerman M, Todd R, Wong DT. 2000. p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein. Mol Cell Biol 20:6300-6307. (Pubitemid 30650216)
32. Shintani S, Mihara M, Terakado N, Nakahara Y, Matsumura T, Kohno Y, Ohyama H, McBride J, Kent R, Todd R, Tsuji T, Wong DT. 2001. Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma. Clin Cancer Res 7:2776-2782. (Pubitemid 32911384)
33. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. 2007. miR-21-mediated tumor growth. Oncogene 26:2799-2803. (Pubitemid 46663837)
34. Terret ME, Lefebvre C, Djiane A, Rassinier P, Moreau J, Maro B, Verlhac MH. 2003. DOC1R: A MAP kinase substrate that control microtubule organization of metaphase II mouse oocytes. Development 130:5169-5177. (Pubitemid 37369676)
35. Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, Chou MY, Chiang T, Wong DT. 1995. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J 9:1362-1370.
36. Todd R, Donoff RB, Wong DT. 1997. The molecular biology of oral carcinogenesis: Toward a tumor progression model. J Oral Maxillofac Surg 55:613-623; discussion 623-625.
37. Tsuji T, Duh FM, Latif F, Popescu NC, Zimonjic DB, McBride J, Matsuo K, Ohyama H, Todd R, Nagata E, Terakado N, Sasaki A, Matsumura T, Lerman MI, Wong DT. 1998. Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1. J Biol Chem 273:6704-6709. (Pubitemid 28160329)
38. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. 2005. Cell migration and invasion assays. Methods 37:208-215. (Pubitemid 41587431)
39. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198. (Pubitemid 43357945)
40. Yuan Z, Sotsky Kent T, Weber TK. 2003. Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer. Oncogene 22:6304-6310. (Pubitemid 37281661)
41. Zamore PD, Haley B. 2005. Ribo-gnome: The big world of small RNAs. Science 309:1519-1524. (Pubitemid 41266468)